Device Tax Foes Seize Opportunity in Budget Impasse
Bipartisan support exists for a repeal of the medical device tax, but only if it doesn't impede implementation of the Affordable Care Act.
Increased Life Spans Come at a Price
Finding a way to promote longevity without promoting harmful side effects is a key goal of longevity proponents and researchers, but new work on aging in mice points to the challenge ahead.
Improper Drug Use Wastes $200B a Year
In 2012, an estimated $213 billion in health care spending in the United States was wasted on improper and unnecessary use of medicines. Those avoidable costs could have paid to insure 24 million Americans.
New Class of Antibiotics on the Horizon
A team of researchers has discovered what could become a new and more effective kind of antibiotic that disrupts protein synthesis in bacteria and makes them unable to replicate.
Incentives Reward Surgical Complications
A study analyzing the relationship between major complications and hospital costs and profits revealed that surgical complications can yield hospital profits of as much as 330% while improving quality is perversely penalized.
Insurers Seeking More for Their Money
Despite steps made by the top private health plans in the U.S., a nationwide survey indicates little progress has been made in promoting value-based care during the last two years.
The Computer Will See You Now
Indiana University researchers have created an artificial intelligence system able to improve patient health care while at the same time reducing costs.
Gov't Recovers Record $4.2 Billion Lost to Fraud
A record $4.2 billion in health care fraud judgements and settlements was returned to federal programs in 2012. The majority of detected fraud relates to health care services delivery and billing; however, the pharmaceutical industry also contributed.
Cancer Deaths, Rates Continue Decline in U.S.
The number of cancer cases continues to drop for most American men and women, according to an annual update of cancer incidence, mortality, and trends in the United States.
EU Leaders Agree on Patent Package
After almost 40 years of talks, European Union leaders agreed to cut patent fees by 80%, making the EU more competitive with the United States and Japan in attracting inventors.
U.K. to Map DNA of Up to 100,000 Patients
The U.K.'s National Health Service will map the DNA of up to 100,000 patients with cancer and other rare diseases in hopes of accelerating diagnosis, improving treatment and sparking innovation.
Gaps and Ambiguities in FDA Jurisdiction Fail Consumers
The FDA's legal standing to mandate reviews and inspect compounding pharmacies has not always been clear-cut. After the meningitis outbreak stemming from a Massachusetts compounding pharmacy, the FDA commissioner is arguing for expanded authority.
2 Clarke Drive Cranbury, NJ 08512